FINERENONE belongs to a class of drugs known as mineralocorticoid receptor (MR) antagonists. It is used to treat patients with chronic renal damage caused by type 2 diabetes. FINERENONE also lowered the occurrence of new-onset heart failure considerably. Chronic renal disease is defined by a gradual kidney function decline over time. Type 2 diabetes occurs when your body cannot maintain normal blood sugar levels.
FINERENONE contains the active substance finerenone. It works by blocking the action of certain hormones (mineralocorticoids) that can damage your kidneys and heart.
To treat your condition effectually, continue using FINERENONE for as long as your doctor has prescribed it. FINERENONE may cause high potassium level (hyperkalaemia), weakness or tiredness, feeling sick (nausea), numbness in the hands and lips, decreased pulse rate, low sodium level (hyponatraemia), tiredness, headache, confusion, muscle weakness, spasms or cramps and high uric acid level (hyperuricaemia) in some cases. Most of these side effects do not necessitate medical attention and will resolve gradually over time. If you are experiencing these side effects regularly, consult your doctor.
If you are allergic to any components in this composition, do not take FINERENONE; if in doubt, check with a healthcare expert. You should not use this medication while pregnant unless your doctor says it is absolutely necessary. You should not breastfeed if you are on this medication; it might harm your child. FINERENONE is not recommended for children younger than 18 years old. Do not stop taking FINERENONE on your own unless your doctor advises you to. Your doctor may make this decision after checking your blood. Inform your doctor if you have hyperkalemia (high potassium level), severe renal illness, liver illness, heart failure, or Addison's disease (when your body does not generate enough of the hormones 'cortisol' and 'aldosterone').
Chronic kidney disease (CKD)
FINERENONE contains the active ingredient finerenone. It belongs to a class of drugs known as non-steroidal mineralocorticoid receptor (MR) antagonists. It is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalisation for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes. FINERENONE also lowered the occurrence of new-onset heart failure considerably. It acts by inhibiting the function of specific hormones (mineralocorticoids) that might cause kidney and cardiac damage.
Before taking FINERENONE, inform your doctor about your medical history (heart, liver or kidney impairment) and other medications (especially diuretics, anti-bacterial and potassium salts) you are currently taking to rule out any potential negative effects. If you are allergic to any components in this composition, do not take FINERENONE; if in doubt, check with a healthcare expert. You must not take medicines that belong to the group of ‘strong CYP3A4 inhibitors’ while taking FINERENONE. You should not use this medication while pregnant unless your doctor says it is absolutely necessary. You should not breastfeed if you are on this medication; it might harm your child. This medicine should not be given to children or teenagers under the age of 18 because it is not known whether it is safe and effective in this age group. Do not eat grapefruit or drink grapefruit juice as long as you take FINERENONE.
Drug-drug interactions: FINERENONE may interact with antifungal medications (e.g. itraconazole or ketoconazole), HIV medications (e.g. ritonavir, nelfinavir, or cobicistat) and anti-depression medicines (e.g. nefazodone).
Drug-food interactions: Reduce the consumption of potassium and phosphate in your diet. Do not consume grapefruit or grapefruit juice while taking FINERENONE.
Drug-disease interactions: FINERENONE should be used with caution in patients with a high potassium level in the blood, severe renal function loss or failure, liver difficulties, heart failure, or Addison's disease (when your body does not generate enough of the hormones 'cortisol' and 'aldosterone').
It is not known if alcohol interacts with FINERENONE. Please consult the doctor.
You should not use this medication while pregnant unless your doctor says it is absolutely necessary.
You should not breastfeed if you are on this medication. It might harm your child.
FINERENONE has no effect on your ability to drive or use machines. But drive only if you are alert, as the FINERENONE may cause weakness or tiredness in some people.
Caution should be exercised while using FINERENONE in patients with liver impairment. If you have a pre-existing or a history of liver disease, inform your doctor before taking the FINERENONE. Your doctor will weigh the benefits and potential risks before prescribing FINERENONE.
FINERENONE can be taken safely when prescribed.
This medicine should not be given to children or teenagers under the age of 18 because it is not known whether it is safe and effective in this age group.
Chronic kidney disease: Chronic kidney disease, also known as chronic kidney failure, is a long-term kidney condition that results in renal failure. Kidneys remove waste and extra fluid from the blood. Renal disease is characterised by a steady decline of kidney function over time. As a result, waste can accumulate to dangerously high levels in the blood, potentially making you sick. Loss of appetite, nausea, vomiting, sleep problems, and swelling of the feet and ankles are the symptoms of renal failure. Treatment focuses mostly on stopping the progression of kidney disease by addressing the underlying cause.